Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Cogent Biosciences (COGT) Asset Utilization Ratio (2018 - 2020)

Cogent Biosciences' Asset Utilization Ratio history spans 3 years, with the latest figure at 0.04 for Q4 2020.

  • Quarterly Asset Utilization Ratio fell 90.39% to 0.04 in Q4 2020 from the year-ago period, while the trailing twelve-month figure was 0.04 through Dec 2020, down 90.39% year-over-year, with the annual reading at 0.05 for FY2020, 84.23% down from the prior year.
  • Asset Utilization Ratio came in at 0.04 for Q4 2020, down from 0.27 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.68 in Q2 2020 to a low of 0.04 in Q4 2020.
  • The 3-year median for Asset Utilization Ratio is 0.17 (2019), against an average of 0.25.
  • The largest YoY upside for Asset Utilization Ratio was 374.14% in 2020 against a maximum downside of 90.39% in 2020.
  • Cogent Biosciences' Asset Utilization Ratio stood at 0.11 in 2018, then skyrocketed by 289.25% to 0.42 in 2019, then tumbled by 90.39% to 0.04 in 2020.
  • Per Business Quant, the three most recent readings for COGT's Asset Utilization Ratio are 0.04 (Q4 2020), 0.27 (Q3 2020), and 0.68 (Q2 2020).